DE2020234A1 - Basisch substituierte Derivate des 4(3H)-Chinazolinons - Google Patents
Basisch substituierte Derivate des 4(3H)-ChinazolinonsInfo
- Publication number
- DE2020234A1 DE2020234A1 DE19702020234 DE2020234A DE2020234A1 DE 2020234 A1 DE2020234 A1 DE 2020234A1 DE 19702020234 DE19702020234 DE 19702020234 DE 2020234 A DE2020234 A DE 2020234A DE 2020234 A1 DE2020234 A1 DE 2020234A1
- Authority
- DE
- Germany
- Prior art keywords
- general formula
- quinazolinone
- methyl
- radical
- atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- QMNUDYFKZYBWQX-UHFFFAOYSA-N 1H-quinazolin-4-one Chemical class C1=CC=C2C(=O)N=CNC2=C1 QMNUDYFKZYBWQX-UHFFFAOYSA-N 0.000 title claims description 12
- -1 nitro, amino Chemical group 0.000 claims description 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 7
- 150000001412 amines Chemical class 0.000 claims description 7
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 6
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 125000004070 6 membered heterocyclic group Chemical group 0.000 claims description 3
- 125000003341 7 membered heterocyclic group Chemical group 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 239000004593 Epoxy Substances 0.000 claims description 2
- 101150052863 THY1 gene Proteins 0.000 claims description 2
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims description 2
- 125000001931 aliphatic group Chemical group 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 2
- 150000003335 secondary amines Chemical class 0.000 claims description 2
- 125000004434 sulfur atom Chemical group 0.000 claims description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- 239000002585 base Substances 0.000 description 24
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- 239000000243 solution Substances 0.000 description 12
- AVRPFRMDMNDIDH-UHFFFAOYSA-N 1h-quinazolin-2-one Chemical class C1=CC=CC2=NC(O)=NC=C21 AVRPFRMDMNDIDH-UHFFFAOYSA-N 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- BTJMOXDWIPVCRO-UHFFFAOYSA-N 2,3,4-trimethoxybenzamide Chemical compound COC1=CC=C(C(N)=O)C(OC)=C1OC BTJMOXDWIPVCRO-UHFFFAOYSA-N 0.000 description 2
- PXBFMLJZNCDSMP-UHFFFAOYSA-N 2-Aminobenzamide Chemical compound NC(=O)C1=CC=CC=C1N PXBFMLJZNCDSMP-UHFFFAOYSA-N 0.000 description 2
- GGNMTJKRHHLJHH-UHFFFAOYSA-N 3,4,5-trimethoxybenzamide Chemical compound COC1=CC(C(N)=O)=CC(OC)=C1OC GGNMTJKRHHLJHH-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 239000013067 intermediate product Substances 0.000 description 2
- 229940072033 potash Drugs 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 235000015320 potassium carbonate Nutrition 0.000 description 2
- BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical compound [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- SEPPVOUBHWNCAW-FNORWQNLSA-N (E)-4-oxonon-2-enal Chemical compound CCCCCC(=O)\C=C\C=O SEPPVOUBHWNCAW-FNORWQNLSA-N 0.000 description 1
- HTWMTDKMOSSPMU-UHFFFAOYSA-N 1,2-benzoxazin-4-one Chemical compound C1=CC=C2C(=O)C=NOC2=C1 HTWMTDKMOSSPMU-UHFFFAOYSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- NSMWYRLQHIXVAP-UHFFFAOYSA-N 2,5-dimethylpiperazine Chemical compound CC1CNC(C)CN1 NSMWYRLQHIXVAP-UHFFFAOYSA-N 0.000 description 1
- DOIYVYPDJIWHTO-UHFFFAOYSA-N 2-(4-chlorophenyl)-6,7,8-trimethoxy-1h-quinazolin-4-one Chemical compound N1=C2C(OC)=C(OC)C(OC)=CC2=C(O)N=C1C1=CC=C(Cl)C=C1 DOIYVYPDJIWHTO-UHFFFAOYSA-N 0.000 description 1
- XNIOWJUQPMKCIJ-UHFFFAOYSA-N 2-(benzylamino)ethanol Chemical compound OCCNCC1=CC=CC=C1 XNIOWJUQPMKCIJ-UHFFFAOYSA-N 0.000 description 1
- WFCSWCVEJLETKA-UHFFFAOYSA-N 2-piperazin-1-ylethanol Chemical compound OCCN1CCNCC1 WFCSWCVEJLETKA-UHFFFAOYSA-N 0.000 description 1
- 125000005809 3,4,5-trimethoxyphenyl group Chemical group [H]C1=C(OC([H])([H])[H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 1
- KRGXWTOLFOPIKV-UHFFFAOYSA-N 3-(methylamino)propan-1-ol Chemical compound CNCCCO KRGXWTOLFOPIKV-UHFFFAOYSA-N 0.000 description 1
- LLBZPESJRQGYMB-UHFFFAOYSA-N 4-one Natural products O1C(C(=O)CC)CC(C)C11C2(C)CCC(C3(C)C(C(C)(CO)C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)CO5)OC5C(C(OC6C(C(O)C(O)C(CO)O6)O)C(O)C(CO)O5)OC5C(C(O)C(O)C(C)O5)O)O4)O)CC3)CC3)=C3C2(C)CC1 LLBZPESJRQGYMB-UHFFFAOYSA-N 0.000 description 1
- COQLCQBAUUTTKB-UHFFFAOYSA-N 6,7,8-trimethoxy-2-phenyl-1h-quinazolin-4-one Chemical compound COC1=C(OC)C(OC)=CC(C(N=2)=O)=C1NC=2C1=CC=CC=C1 COQLCQBAUUTTKB-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 101100400378 Mus musculus Marveld2 gene Proteins 0.000 description 1
- OPKOKAMJFNKNAS-UHFFFAOYSA-N N-methylethanolamine Chemical compound CNCCO OPKOKAMJFNKNAS-UHFFFAOYSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000005078 alkoxycarbonylalkyl group Chemical group 0.000 description 1
- 125000005263 alkylenediamine group Chemical group 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 229940125681 anticonvulsant agent Drugs 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical compound C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 125000005265 dialkylamine group Chemical group 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- WEHWNAOGRSTTBQ-UHFFFAOYSA-N dipropylamine Chemical compound CCCNCCC WEHWNAOGRSTTBQ-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 150000002431 hydrogen Chemical group 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- WGYKZJWCGVVSQN-UHFFFAOYSA-N mono-n-propyl amine Natural products CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 1
- RIWRFSMVIUAEBX-UHFFFAOYSA-N n-methyl-1-phenylmethanamine Chemical compound CNCC1=CC=CC=C1 RIWRFSMVIUAEBX-UHFFFAOYSA-N 0.000 description 1
- VEBLEROFGPOMPB-UHFFFAOYSA-N n-methylcyclopropanamine Chemical compound CNC1CC1 VEBLEROFGPOMPB-UHFFFAOYSA-N 0.000 description 1
- SASNBVQSOZSTPD-UHFFFAOYSA-N n-methylphenethylamine Chemical compound CNCCC1=CC=CC=C1 SASNBVQSOZSTPD-UHFFFAOYSA-N 0.000 description 1
- IOXXVNYDGIXMIP-UHFFFAOYSA-N n-methylprop-2-en-1-amine Chemical compound CNCC=C IOXXVNYDGIXMIP-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- YZTJYBJCZXZGCT-UHFFFAOYSA-N phenylpiperazine Chemical compound C1CNCCN1C1=CC=CC=C1 YZTJYBJCZXZGCT-UHFFFAOYSA-N 0.000 description 1
- 125000006308 propyl amino group Chemical group 0.000 description 1
- AOHJOMMDDJHIJH-UHFFFAOYSA-N propylenediamine Chemical compound CC(N)CN AOHJOMMDDJHIJH-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- WYROLENTHWJFLR-ACLDMZEESA-N queuine Chemical compound C1=2C(=O)NC(N)=NC=2NC=C1CN[C@H]1C=C[C@H](O)[C@@H]1O WYROLENTHWJFLR-ACLDMZEESA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
- C07D265/22—Oxygen atoms
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B25—HAND TOOLS; PORTABLE POWER-DRIVEN TOOLS; MANIPULATORS
- B25H—WORKSHOP EQUIPMENT, e.g. FOR MARKING-OUT WORK; STORAGE MEANS FOR WORKSHOPS
- B25H7/00—Marking-out or setting-out work
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19702020234 DE2020234A1 (de) | 1970-04-25 | 1970-04-25 | Basisch substituierte Derivate des 4(3H)-Chinazolinons |
| NL7105069A NL7105069A (enExample) | 1970-04-25 | 1971-04-15 | |
| US00136556A US3748327A (en) | 1970-04-25 | 1971-04-22 | Basically substituted 4(3h)-quinazolinone derivatives |
| CH596271A CH556343A (de) | 1970-04-25 | 1971-04-23 | Verfahren zur herstellung basisch substituierter derivate des 4(3h)-chinazolinons. |
| BE766242A BE766242A (fr) | 1970-04-25 | 1971-04-23 | Derives de la 4(3h-)-quinazolinone et leur |
| FR7114532A FR2092090B1 (enExample) | 1970-04-25 | 1971-04-23 | |
| GB1117671*[A GB1312391A (en) | 1970-04-25 | 1971-04-23 | Basically substituted 4 3h- quinazolinone derivatives and process for their manufacture |
| CA111158A CA932332A (en) | 1970-04-25 | 1971-04-23 | Basically substituted 4(3h)-quinazolinone derivatives and processes for their manufacture |
| AT352071A AT306028B (de) | 1970-04-25 | 1971-04-23 | Verfahren zur Herstellung neuer basisch substituierter Derivate des 4(3H)-Chinazolinons |
| AT351971A AT306027B (de) | 1970-04-25 | 1971-04-23 | Verfahren zur Herstellung neuer basisch substituierter Derivate des 4(3H)-Chinazolinons |
| CH596371A CH553790A (de) | 1970-04-25 | 1971-04-23 | Verfahren zur herstellung basisch substituierter derivate des 4 (3h)-chinazolinons. |
| CH596471A CH553788A (de) | 1970-04-25 | 1971-04-23 | Verfahren zur herstellung basisch substituierter derivate des 4 (3h)-chinazolinons. |
| AT352171A AT306029B (de) | 1970-04-25 | 1971-04-23 | Verfahren zur Herstellung neuer basisch substituierter Derivate des 4(3H)-Chinazolinons |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19702020234 DE2020234A1 (de) | 1970-04-25 | 1970-04-25 | Basisch substituierte Derivate des 4(3H)-Chinazolinons |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2020234A1 true DE2020234A1 (de) | 1971-11-18 |
Family
ID=5769324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19702020234 Pending DE2020234A1 (de) | 1970-04-25 | 1970-04-25 | Basisch substituierte Derivate des 4(3H)-Chinazolinons |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US3748327A (enExample) |
| AT (3) | AT306027B (enExample) |
| BE (1) | BE766242A (enExample) |
| CA (1) | CA932332A (enExample) |
| CH (3) | CH553790A (enExample) |
| DE (1) | DE2020234A1 (enExample) |
| FR (1) | FR2092090B1 (enExample) |
| GB (1) | GB1312391A (enExample) |
| NL (1) | NL7105069A (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4883787A (en) * | 1985-07-29 | 1989-11-28 | Ortho Pharmaceutical Corporation | Process for preparing 2-acyl-3, 4-dialkoxyanilines |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2639291A1 (de) * | 1976-09-01 | 1978-03-02 | Thomae Gmbh Dr K | Neue aryl-alkylamine |
| DE2914915A1 (de) * | 1979-04-12 | 1980-10-30 | Basf Ag | 4h-3,1-benzoxazinderivate |
| JPS6136273A (ja) * | 1984-07-26 | 1986-02-20 | Mitsubishi Yuka Yakuhin Kk | ２−フエニルアルキル−４（３ｈ）−キナゾリノン誘導体 |
| US4762838A (en) * | 1985-08-30 | 1988-08-09 | Pfizer Inc. | Quinazolin-4(3H)-one derivatives as anticoccidial agents |
| US4849518A (en) * | 1987-06-22 | 1989-07-18 | Pfizer Inc. | Quinazolin-4(3H)-one derivatives as anticoccidial agents |
| US4920224A (en) * | 1988-03-24 | 1990-04-24 | Pfizer Inc. | Quinazolin-4(3H)-one derivatives as anticoccidial agents |
| JPH0687835A (ja) * | 1992-07-17 | 1994-03-29 | Rohm & Haas Co | 除草性２−アリール−５，６−縮合環−ピリミジン |
| WO1997010221A1 (en) * | 1995-09-15 | 1997-03-20 | Torrey Pines Institute For Molecular Studies | Synthesis of quinazolinone libraries |
| CA2737219C (en) * | 2008-08-11 | 2017-02-28 | Tracy Keller | Halofuginone analogs for inhibition of trna synthetases and uses thereof |
| US10155742B2 (en) | 2012-01-13 | 2018-12-18 | President And Fellows Of Harvard College | Halofuginol derivatives and their use in cosmetic and pharmaceutical compositions |
| US11708353B2 (en) | 2018-06-08 | 2023-07-25 | The General Hospital Corporation | Inhibitors of prolyl-tRNA-synthetase |
-
1970
- 1970-04-25 DE DE19702020234 patent/DE2020234A1/de active Pending
-
1971
- 1971-04-15 NL NL7105069A patent/NL7105069A/xx unknown
- 1971-04-22 US US00136556A patent/US3748327A/en not_active Expired - Lifetime
- 1971-04-23 AT AT351971A patent/AT306027B/de not_active IP Right Cessation
- 1971-04-23 AT AT352071A patent/AT306028B/de not_active IP Right Cessation
- 1971-04-23 BE BE766242A patent/BE766242A/xx unknown
- 1971-04-23 CH CH596371A patent/CH553790A/xx not_active IP Right Cessation
- 1971-04-23 GB GB1117671*[A patent/GB1312391A/en not_active Expired
- 1971-04-23 CH CH596471A patent/CH553788A/xx not_active IP Right Cessation
- 1971-04-23 FR FR7114532A patent/FR2092090B1/fr not_active Expired
- 1971-04-23 AT AT352171A patent/AT306029B/de not_active IP Right Cessation
- 1971-04-23 CH CH596271A patent/CH556343A/xx not_active IP Right Cessation
- 1971-04-23 CA CA111158A patent/CA932332A/en not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4883787A (en) * | 1985-07-29 | 1989-11-28 | Ortho Pharmaceutical Corporation | Process for preparing 2-acyl-3, 4-dialkoxyanilines |
Also Published As
| Publication number | Publication date |
|---|---|
| NL7105069A (enExample) | 1971-10-27 |
| FR2092090A1 (enExample) | 1972-01-21 |
| FR2092090B1 (enExample) | 1975-08-01 |
| AT306027B (de) | 1973-03-26 |
| GB1312391A (en) | 1973-04-04 |
| AT306029B (de) | 1973-03-26 |
| CA932332A (en) | 1973-08-21 |
| CH553788A (de) | 1974-09-13 |
| CH556343A (de) | 1974-11-29 |
| US3748327A (en) | 1973-07-24 |
| CH553790A (de) | 1974-09-13 |
| BE766242A (fr) | 1971-10-25 |
| AT306028B (de) | 1973-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1231705B (de) | Verfahren zur Herstellung von 2, 3-substituierten Chinazolon-(4)-derivaten | |
| DE2020234A1 (de) | Basisch substituierte Derivate des 4(3H)-Chinazolinons | |
| DE60318733T2 (de) | Substituierte benzoxazinones und ihre verwendung | |
| EP0005828A1 (de) | Neue substituierte Phenylpiperazinderivate, diese enthaltende Arzneimittel und Verfahren zu deren Herstellung | |
| DE69529619T4 (de) | Pyrimidinylpyrazolderivative | |
| DE69521037T2 (de) | Chinazolinylamino derivate mit alfa-antagonist wirkung | |
| DE2332731A1 (de) | Chinolin-carbonsaeure-(2)-verbindungen, verfahren zu ihrer herstellung sowie solche verbindungen enthaltende arzneimittelpraeparate | |
| DE69109066T2 (de) | Benzoxazinon- und Benzothiazinonderivate mit kardiovaskularer Wirksamkeit. | |
| DE69320087T2 (de) | Benzoxazinon- und Benzothiazinonderivate mit kardiovasculärer Wirkung | |
| CH534687A (de) | Verfahren zur Herstellung von Derivaten des 2-Oxo-1,2-dihydro-chinolins | |
| DE2131034A1 (de) | Acylharnstoffe und verfahren zu ihrer herstellung | |
| DE1934037A1 (de) | Basisch substituierte Derivate des 2,4-(1H,3H)-Chinazolindions | |
| EP0139627B1 (de) | Verfahren zur Herstellung von neuen in 5-Stellung substituierten 5,10-Dihydro-11H-dibenzo(b,e)(1,4)diazepin-11-onen | |
| DE1076691B (de) | Verfahren zur Herstellung von Phenthiazinderivaten | |
| DE1926076A1 (de) | Basisch substituierte Derivate des 1,2,3-Benzotriazin-4(3H)-ons | |
| US3525748A (en) | Certain 2-amino-3-phenyl-3,4-dihydroquinazolin-4-ones | |
| DE2020233A1 (de) | Basisch substituierte Derivate des 4(3H)-Chinazolinons | |
| Okumura et al. | 4-Oxo-1, 2, 3, 4-tetrahydroquinazolines. 3. Synthesis and choleretic activity of quinazoline derivatives | |
| CH496020A (de) | Verfahren zur Herstellung von Benzothiadiazin-1,1-dioxyden | |
| US2488379A (en) | Quinazoline derivatives | |
| EP0599152A1 (de) | Triazinone une Triazinophthalazinone mit antiasthmatischer/antiallergischer, positiv inotroper und blutdrucksenkender Wirkung | |
| AT258919B (de) | Verfahren zur Herstellung neuer 2-Methyl-3-phenyl-3H-4-chinazolone | |
| DE1189552B (de) | Verfahren zur Herstellung von 2-Oxo-1, 2-dihydrochinoxalinen und von deren Salzen und quaternaeren Ammoniumverbindungen | |
| Sharma et al. | Synthesis of bioactive molecule fluoro benzothiazole comprising quinazolinyl oxadiazoles derivative for biological and pharmacological screening | |
| DE1620179A1 (de) | Verfahren zur Herstellung neuer basischer Derivate des Benzoxazins |